Conference item icon

Conference item

Transfusions in people with haematological malignancies – Results of a repeat UK national comparative audit with improvement in practice

Subtitle:
Conference abstract
Abstract:
Red cell and platelet transfusions are essential in the management of people with haematological malignancies and bone marrow failure disorders. Up to 65% of platelet components and 25% of red cell components issued are given to haematology patients, and most are used in the elderly. As the UK population is ageing, with a predicted doubling in people aged 85 years by 2041, only using red cell and platelet transfusion to those likely to benefit is imperative to minimise side effects, limit costs, and maintain the blood supply.
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted Manuscript

Actions


Access Document


Files:
Publisher copy:
10.1111/vox.12658

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
RDM
Subgroup:
RDM Clinical Laboratory Sciences
Role:
Author
ORCID:
0000-0003-4309-9162
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
RDM
Subgroup:
RDM Clinical Laboratory Sciences
Role:
Author
Publisher:
Wiley Publisher's website
Volume:
113
Issue:
S1
Pages:
P709
Publication date:
2018-05-22
Acceptance date:
2018-05-01
DOI:
EISSN:
1423-0410
Pubs id:
pubs:921524
URN:
uri:8456ad73-2d5a-4f41-8a8c-a689d45a214e
UUID:
uuid:8456ad73-2d5a-4f41-8a8c-a689d45a214e
Local pid:
pubs:921524

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP